These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 315822)

  • 1. Bovine dialyzable lymph node extracts have antigen-dependent and antigen-independent effects on human cell-mediated immunity in vitro.
    Wilson GB; Newell RT; Burdash NM
    Cell Immunol; 1979 Sep; 47(1):1-18. PubMed ID: 315822
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro transfer of specific reactivity to cytomegalovirus and candida to cord blood leukocytes with dialyzable leukocyte extracts.
    Sirianni MC; Fiorilli M; Paná A; Pezzella M; Aiuti F
    Clin Immunol Immunopathol; 1979 Nov; 14(3):300-6. PubMed ID: 227634
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of cell-mediated responses with dialyzable leukocyte extract containing transfer factor.
    Klesius PH
    Adv Exp Med Biol; 1981; 137():293-323. PubMed ID: 6174037
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of dialyzable lymph node extracts on lymphoblast proliferative capacity of blood mononuclear cells in cattle with chronic paratuberculosis.
    Kreeger JM; Snider TG; Olcott BM
    Am J Vet Res; 1992 Jul; 53(7):1225-30. PubMed ID: 1497195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dialyzable leukocyte extracts (DLEs) with transfer factor activity on leukocyte migration in vitro. III. Characterization of the antigen-independent migration inhibition factor in DLEs as a neutrophil immobilizing factor.
    Wilson GB; Smith CL; Fudenberg HH
    J Allergy Clin Immunol; 1979 Jul; 64(1):56-66. PubMed ID: 447952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transfer of delayed type hypersensitivity in guinea pigs].
    Smogorzewska E
    Probl Med Wieku Rozwoj; 1990; 16():167-88. PubMed ID: 2152405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro transfer of cell-mediated immunity to hepatitis B antigen with RNA.
    Vyas GN; Ibrahim AB; Rao KR; Likhite V
    Nature; 1974 Feb; 247(5440):377-8. PubMed ID: 4817858
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppressor cell influence in selected strains of inbred rats. I. Strain-dependent mitogen- and antigen-related low responsiveness.
    Raff HV; Hinrichs DJ
    Cell Immunol; 1977 Mar; 29(1):96-108. PubMed ID: 403016
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of dialyzable leukocyte extracts (DLE) with transfer factor activity on leukocyte migration in vitro. IV. Two distinct effects of DLE on leukocyte migration can be produced by prostaglandins.
    Wilson GB; Fudenberg HH; Jonsson HT; Smith CL
    Clin Immunol Immunopathol; 1980 May; 16(1):90-102. PubMed ID: 7379353
    [No Abstract]   [Full Text] [Related]  

  • 10. Distinct components in dialyzable leukocyte extracts (DLE) have specific and nonspecific effects on cellular immunity as shown by leukocyte migration inhibition.
    Wilson GB; Fudenberg HH; Bahm VJ
    Trans Assoc Am Physicians; 1978; 91():295-332. PubMed ID: 754397
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immunity: correlation of mixed-leucocyte-macrophage migration inhibition with delayed-type hypersensitivity after immunization and donor-specific transfer of cell migration inhibition by dialyzable leucocyte extract.
    Mazaheri R; Hamblin AS; Zuckerman AJ
    Cell Immunol; 1983 Nov; 82(1):147-62. PubMed ID: 6196129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migration inhibition of lymph node lymphocytes as an in vitro assay for cell-mediated immunity in the draining lymph nodes of parenterally immunized mice.
    Mowat AM; Ferguson A
    Immunology; 1982 Oct; 47(2):357-64. PubMed ID: 6180978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Participation of cellular immunity mediators in the development of anti-infection resistance].
    Medunitsyn NV
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Oct; (10):9-14. PubMed ID: 371279
    [No Abstract]   [Full Text] [Related]  

  • 14. Human T lymphcytes are enriched for transfer factor.
    Tomar RH; John PA
    J Immunol; 1980 Mar; 124(3):1054-7. PubMed ID: 6965683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies on dialyzable leukocyte extracts containing transfer factor--a review.
    Klesius PH; Fudenberg HH; Smith CL
    Comp Immunol Microbiol Infect Dis; 1980; 3(3):247-60. PubMed ID: 6162606
    [No Abstract]   [Full Text] [Related]  

  • 16. Nature and activities of transfer factor.
    Petersen EA; Kirkpatrick CH
    Ann N Y Acad Sci; 1979; 332():216-27. PubMed ID: 231399
    [No Abstract]   [Full Text] [Related]  

  • 17. Specificity of the local transfer of cell-mediated immunity with dialyzable transfer factor.
    Gerbase-DeLima M; Carlquist I; Mendes NF
    Cell Immunol; 1979 Nov; 48(1):231-4. PubMed ID: 509535
    [No Abstract]   [Full Text] [Related]  

  • 18. Mediators of cellular immunity, their nature and assay.
    Rocklin RE
    J Invest Dermatol; 1976 Sep; 67(3):372-80. PubMed ID: 184210
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfer of cell-mediated immunity with cell-free leukocyte extracts. II. Demonstration of antigen-specific and nonspecific components.
    Croft S; Edwards JM; Basten A
    Cell Immunol; 1980 Dec; 56(2):427-39. PubMed ID: 6970628
    [No Abstract]   [Full Text] [Related]  

  • 20. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part I. Introduction. (first of three parts).
    Ablin RJ
    Allergol Immunopathol (Madr); 1980; 8(1):53-60. PubMed ID: 6996464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.